Oral GW766944 (Oral CCR3 Antagonist)
Clinical trial NCT01160224 · COMPLETED
Trial details
- NCT number
- NCT01160224
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-08
- Primary completion
- 2011-08-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.